Hua Medicine stock forecast
Hua Medicine (HUMDF) Stock Forecast & Price Target
HUMDF Analyst Ratings
HUMDF Stock 12 Month Forecast
Average Price Target
$0.45▲(61.40% Upside)Detailed List of Analyst Forecasts​
Best Analysts Covering Hua Medicine
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +18.45% per trade.
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +32.40% per trade.
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.40% per trade.
HUMDF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 1 | 1 | 1 |
In the current month, HUMDF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HUMDF average Analyst price target in the past 3 months is 0.45.
HUMDF Financial Forecast
HUMDF Earnings Forecast
Next quarter’s earnings estimate for HUMDF is $0.00 with a range of ― to ―. The previous quarter’s EPS was $0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HUMDF Sales Forecast
Next quarter’s sales forecast for HUMDF is $55.06M with a range of ― to ―. The previous quarter’s sales results were $55.06M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
